Talphera (TLPH)

• Market cap: $43.9M
• 1 day: 9.26%
• 5 days: 8.19%
• 1 month: -6.3%
• 3 months: -4.99%
• 6 months: -34.36%
• Year to date: -27%
• 1 year: 64.4%
• 5 years: -97.46%
• 10 years: -98.78%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 12